Form 25-NSE Viking Therapeutics, Filed by: Nasdaq Stock Market LLC
- Nasdaq, S&P 500 fall as Amazon earnings disappoint
- Amazon (AMZN) Plunges After Missing Sales and Guidance Expectations, Analysts Slash PTs to Reflect Weaker Guidance
- Pinterest (PINS) Tops Profit and Sales Views, But Shares Plunges Over 20% on a Big Monthly User Miss to Prompt Two Downgrades
- Bullard: Fed should taper this fall, go "fairly rapidly" to end early 2022
- Qualtrics International (XM) to Acquire Clarabridge
Get instant alerts when news breaks on your stocks. Claim your 1-week free trial to StreetInsider Premium here.
X0203 0001354457 Nasdaq Stock Market LLC 0001607678 Viking Therapeutics, Inc. 001-37355 11119 North Torrey Pines Road, Suite 50 San Diego CA CALIFORNIA 92037 858-550-7810 Viking Therapeutics, Inc. Warrants expiring 04/13/2021 17 CFR 240.12d2-2(a)(2) Tara Petta Director 2021-04-08
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Viking Therapeutic (VKTX) PT Raised to $13 at Raymond James
- Accenture Completes Acquisition of Ethica Consulting Group
- Annual Financial Report
Create E-mail Alert Related CategoriesSEC Filings
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!